MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Intuitive Surgical Inc

Fermé

SecteurSoins de santé

494.57 -2.54

Résumé

Variation du prix de l'action

24h

Actuel

Min

484.44

Max

505.57

Chiffres clés

By Trading Economics

Revenu

123M

688M

Ventes

374M

2.4B

P/E

Moyenne du Secteur

76.905

63.778

BPA

2.21

Marge bénéficiaire

28.506

Employés

15,638

EBITDA

116M

810M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+26.58% upside

Dividendes

By Dow Jones

Prochains Résultats

22 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-30B

177B

Ouverture précédente

497.11

Clôture précédente

494.57

Sentiment de l'Actualité

By Acuity

18%

82%

35 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Intuitive Surgical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 janv. 2025, 21:41 UTC

Résultats

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 janv. 2025, 18:37 UTC

Acquisitions, Fusions, Rachats

Intuitive to Establish Direct Presence in Europe With Acquisition

18 oct. 2024, 15:22 UTC

Résultats
Principaux Mouvements du Marché

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17 oct. 2024, 21:33 UTC

Résultats
Principaux Mouvements du Marché

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 oct. 2024, 20:56 UTC

Résultats

Intuitive Surgical Posts 3Q Revenue Growth

24 janv. 2025, 21:17 UTC

Résultats

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 janv. 2025, 18:18 UTC

Résultats

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 janv. 2025, 13:11 UTC

Actualités

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 janv. 2025, 09:51 UTC

Actions en Tendance

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 janv. 2025, 21:10 UTC

Résultats

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 janv. 2025, 21:09 UTC

Résultats

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 janv. 2025, 21:09 UTC

Résultats

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q Net $685.7M >ISRG

23 janv. 2025, 21:05 UTC

Résultats

Intuitive Surgical 4Q EPS $1.88 >ISRG

15 janv. 2025, 17:27 UTC

Résultats

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6 janv. 2025, 12:00 UTC

Actualités

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18 oct. 2024, 15:59 UTC

Résultats

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18 oct. 2024, 15:38 UTC

Résultats

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18 oct. 2024, 13:28 UTC

Résultats

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17 oct. 2024, 21:18 UTC

Résultats
Principaux Mouvements du Marché

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17 oct. 2024, 20:22 UTC

Résultats

Intuitive Surgical Adds To 41% Run With Massive Profit Beat, Strong Procedure Growth -- IBD

17 oct. 2024, 20:05 UTC

Résultats

Intuitive Surgical 3Q Adj EPS $1.84 >ISRG

17 oct. 2024, 20:05 UTC

Résultats

Intuitive Surgical 3Q Rev $2.04B >ISRG

17 oct. 2024, 20:05 UTC

Résultats

Intuitive Surgical 3Q EPS $1.56 >ISRG

17 oct. 2024, 20:05 UTC

Résultats

Intuitive Surgical 3Q Net $565.1M >ISRG

19 juil. 2024, 13:50 UTC

Principaux Événements d'Actualité

Dow Jones, Other Indexes Open Lower As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

19 juil. 2024, 13:10 UTC

Principaux Événements d'Actualité

Dow Jones Futures Lower, S&P Higher As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

Comparaison

Variation de prix

Intuitive Surgical Inc prévision

Objectif de Prix

By TipRanks

26.58% hausse

Prévisions sur 12 Mois

Moyen 641.83 USD  26.58%

Haut 711 USD

Bas 570 USD

Basé sur 22 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

22 ratings

16

Achat

6

Maintien

0

Vente

Score Technique

By Trading Central

492.06 / 508.58Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

35 / 386Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.